These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
488 related articles for article (PubMed ID: 34261487)
21. Update on neurological manifestations of COVID-19. Yavarpour-Bali H; Ghasemi-Kasman M Life Sci; 2020 Sep; 257():118063. PubMed ID: 32652139 [TBL] [Abstract][Full Text] [Related]
22. A Review of Neurological Involvement in Patients with SARS-CoV-2 Infection. Xu Y; Zhuang Y; Kang L Med Sci Monit; 2021 Jun; 27():e932962. PubMed ID: 34145211 [TBL] [Abstract][Full Text] [Related]
23. Replication Kinetics, Cell Tropism, and Associated Immune Responses in SARS-CoV-2- and H5N1 Virus-Infected Human Induced Pluripotent Stem Cell-Derived Neural Models. Bauer L; Lendemeijer B; Leijten L; Embregts CWE; Rockx B; Kushner SA; de Vrij FMS; van Riel D mSphere; 2021 Jun; 6(3):e0027021. PubMed ID: 34160239 [TBL] [Abstract][Full Text] [Related]
24. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related]
25. Does COVID-19 contribute to development of neurological disease? Mahalakshmi AM; Ray B; Tuladhar S; Bhat A; Paneyala S; Patteswari D; Sakharkar MK; Hamdan H; Ojcius DM; Bolla SR; Essa MM; Chidambaram SB; Qoronfleh MW Immun Inflamm Dis; 2021 Mar; 9(1):48-58. PubMed ID: 33332737 [TBL] [Abstract][Full Text] [Related]
26. COVID-19 and its effects on neurological functions. Yew MMT; Lip JQ; Ling APK Trop Biomed; 2021 Sep; 38(3):435-445. PubMed ID: 34608117 [TBL] [Abstract][Full Text] [Related]
27. SARS-CoV-2 and the brain: A review of the current knowledge on neuropathology in COVID-19. Maiese A; Manetti AC; Bosetti C; Del Duca F; La Russa R; Frati P; Di Paolo M; Turillazzi E; Fineschi V Brain Pathol; 2021 Nov; 31(6):e13013. PubMed ID: 34390282 [TBL] [Abstract][Full Text] [Related]
28. SARS-CoV-2 invasion of the central nervous: a brief review. Siddiqui R; Mungroo MR; Khan NA Hosp Pract (1995); 2021 Aug; 49(3):157-163. PubMed ID: 33554684 [TBL] [Abstract][Full Text] [Related]
29. Neurological manifestations and pathogenic mechanisms of COVID-19. Galea M; Agius M; Vassallo N Neurol Res; 2022 Jul; 44(7):571-582. PubMed ID: 34986754 [TBL] [Abstract][Full Text] [Related]
30. SARS-CoV-2 journey to the brain with a focus on potential role of docosahexaenoic acid bioactive lipid mediators. Hachem M Biochimie; 2021 May; 184():95-103. PubMed ID: 33639198 [TBL] [Abstract][Full Text] [Related]
31. Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients. Jarius S; Pache F; Körtvelyessy P; Jelčić I; Stettner M; Franciotta D; Keller E; Neumann B; Ringelstein M; Senel M; Regeniter A; Kalantzis R; Willms JF; Berthele A; Busch M; Capobianco M; Eisele A; Reichen I; Dersch R; Rauer S; Sandner K; Ayzenberg I; Gross CC; Hegen H; Khalil M; Kleiter I; Lenhard T; Haas J; Aktas O; Angstwurm K; Kleinschnitz C; Lewerenz J; Tumani H; Paul F; Stangel M; Ruprecht K; Wildemann B; J Neuroinflammation; 2022 Jan; 19(1):19. PubMed ID: 35057809 [TBL] [Abstract][Full Text] [Related]
32. Crosstalk between SARS-CoV-2 Infection and Neurological Disorders: A Review. Azhar A; Wali MA; Rashid Q; Khan WH; Al-Hosaini K; Owais M; Kamal MA CNS Neurol Disord Drug Targets; 2023; 22(5):643-658. PubMed ID: 35440321 [TBL] [Abstract][Full Text] [Related]
33. Brain Renin-Angiotensin System: From Physiology to Pathology in Neuronal Complications Induced by SARS-CoV-2. Ahmadi S; Khaledi S Anal Cell Pathol (Amst); 2023; 2023():8883492. PubMed ID: 37575318 [TBL] [Abstract][Full Text] [Related]
34. Neurological involvement in the respiratory manifestations of COVID-19 patients. Tan BH; Liu JM; Gui Y; Wu S; Suo JL; Li YC Aging (Albany NY); 2021 Feb; 13(3):4713-4730. PubMed ID: 33582654 [TBL] [Abstract][Full Text] [Related]
35. The nervous system-A new territory being explored of SARS-CoV-2. Zhang M; Zhou L; Wang J; Wang K; Wang Y; Pan X; Ma A J Clin Neurosci; 2020 Dec; 82(Pt A):87-92. PubMed ID: 33317745 [TBL] [Abstract][Full Text] [Related]
36. Myoclonus status revealing COVID 19 infection. Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232 [TBL] [Abstract][Full Text] [Related]
37. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports. Najjar S; Najjar A; Chong DJ; Pramanik BK; Kirsch C; Kuzniecky RI; Pacia SV; Azhar S J Neuroinflammation; 2020 Aug; 17(1):231. PubMed ID: 32758257 [TBL] [Abstract][Full Text] [Related]
38. Possible mechanism of central nervous system targeting and neurological symptoms of the new-coronavirus (COVID-19): literature review. Jumagaliyeva M; Ayaganov D; Saparbayev S; Tuychibaeva N; Abdelazim IA; Kurmambayev Y; Khamidullina Z; Yessenamanova S Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9420-9428. PubMed ID: 37843354 [TBL] [Abstract][Full Text] [Related]
39. An overview of the neurological aspects in COVID-19 infection. Singh D; Singh E J Chem Neuroanat; 2022 Jul; 122():102101. PubMed ID: 35430271 [TBL] [Abstract][Full Text] [Related]
40. Do SARS-CoV-2 Variants Differ in Their Neuropathogenicity? Bauer L; van Riel D mBio; 2023 Feb; 14(1):e0292022. PubMed ID: 36651750 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]